Coronary Heart Disease Secondary to Familial Hypercholesterolemia: A Fast Killer
Published: 2022-05-18
Page: 135-143
Issue: 2022 - Volume 4 [Issue 1]
Hanane Mechal *
Department of Cardiology, Ibn Rochd University Hospital, Casablanca, Morocco.
Samia Ejjebli
Department of Cardiology, Ibn Rochd University Hospital, Casablanca, Morocco.
Meryem Haboub
Department of Cardiology, Ibn Rochd University Hospital, Casablanca, Morocco.
Salim Arous
Department of Cardiology, Ibn Rochd University Hospital, Casablanca, Morocco.
Mohamed El Ghali Benouna
Department of Cardiology, Ibn Rochd University Hospital, Casablanca, Morocco.
Abdenacer Drighil
Department of Cardiology, Ibn Rochd University Hospital, Casablanca, Morocco.
Leila Azzouzi
Department of Cardiology, Ibn Rochd University Hospital, Casablanca, Morocco.
Rachida Habbal
Department of Cardiology, Ibn Rochd University Hospital, Casablanca, Morocco.
*Author to whom correspondence should be addressed.
Abstract
Familial hypercholesterolemia is an autosomal disorder characterized by increased levels of total cholesterol and low density lipoprotein cholesterol. The FH clinical phenotype has been shown to be associated with increased coronary heart disease and premature death. We report two cases of homozygote familial hypercholesterolemia (IIa) in brothers, presenting coronary artery disease at an early age, with a very disturbed lipid profile, rapidly progressive and diffuse coronary lesions, with the occurrence of early death in both brothers before the age of 30.
Keywords: Familial hypercholesterolemia, homozygous familial hypercholesterolemia, dyslipidemia, coronary heart disease, xanthoma